Previous 10 | Next 10 |
The following slide deck was published by Genomic Health, Inc. in conjunction with this Read more ...
Genomic Health, Inc. (GHDX) Q4 2018 Earnings Conference Call February 20, 2019 04:30 PM ET Company Participants Emily Faucette - Vice President, Corporate Communications & Investor Relations Kim Popovits - Chairman of the Board, Chief Executive Officer and President Brad Cole...
Gainers: SRCI +11.8% . CAR +10.9% . HTZ +7.3% . ALB +5.7% . GHDX +5.6% . More news on: SRC Energy Inc., Avis Budget Group, Inc., Hertz Global Holdings, Inc., Stocks on the move, Read more ...
Genomic Health (NASDAQ: GHDX ): Q4 GAAP EPS of $0.23 misses by $0.05 . More news on: Genomic Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
REDWOOD CITY, Calif. , Feb. 20, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2018 . "2018 was a record year for Genomic Health. We delivered $394.1 million in revenue a...
Genomic Health (NASDAQ: GHDX ) is scheduled to announce Q4 earnings results on Wednesday, February 20th, after market close. The consensus EPS Estimate is $0.28 and the consensus Revenue Estimate is $101.55M Over the last 1 year, GHDX has beaten EPS estimates 75% of the time and has ...
REDWOOD CITY, Calif. , Feb. 13, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Wednesday, February 20 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2018 financial results....
REDWOOD CITY, Calif. , Feb. 5, 2019 /PRNewswire/ -- Genomic Health, Inc . (Nasdaq: GHDX) today announced the publication of results from a multi-center, prospective validation study of the Oncotype DX ® Genomic Prostate Score ® (GPS ™ ) test in newly diagnosed men...
After a very successful 2018, the Smart Money portfolios are off to a rip-roaring start in 2019. Table 1 is a summary of returns for each of the Smart Money strategies during January 2019. Table 1. Summary of returns for all Smart Money strategies The results for January have been outsta...
REDWOOD CITY, Calif. , Jan. 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that, in collaboration with physicians around the world, it has delivered more than 1 million Oncotype DX ® tests to cancer patients worldwide since it made its f...
News, Short Squeeze, Breakout and More Instantly...
Genomic Health Inc. Company Name:
GHDX Stock Symbol:
NASDAQ Market:
Broadly, genetics is the study of genes, their variations and hereditary characteristics. As Live Science describes it , genetics involves looking at how traits are passed on through generations. So what is genetics investing? When it comes to genetics investing, companies in this niche li...
Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth MADISON, Wisconsin , Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its...
REDWOOD CITY, Calif. , Nov. 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) announced that its stockholders voted to approve the company's proposed combination with Exact Sciences Corp (NASDAQ: EXAS) at a special meeting held earlier today. As previously announced...